Doherty, Edel http://orcid.org/0000-0001-8756-8974
Hobbins, Anna
Whitehurst, David G. T.
O’Neill, Ciaran
Funding for this research was provided by:
Health Research Board (RL/13/16)
Article History
Accepted: 30 November 2020
First Online: 22 January 2021
Declarations
:
: This study was funded by the Health Research Board under a Research Leader Award held by Ciaran O’Neill (RL/2013/16).
: Dr. Doherty declares no conflicts of interest. Dr. Hobbins reports grants from the Health Research Board and The EuroQol Research Foundation during the conduct of this study. Dr Whitehurst is a member of the EuroQol group. Dr. O’Neill reports grants from the Health Research Board and The EuroQol Research Foundation during the conduct of the study, and has received grants from Pfizer, Novartis, GSK, AbbVie, and Roche, and personal fees from Astellas, outside the submitted work.
: Ethical approval for this study was granted by NUI Galway Ethics Committee (application number 15/JAN/04).
: The datasets generated and/or analysed during the current study are available from the corresponding author on reasonable request.
: Informed consent was obtained from all individual participants included in the study.
: The individual participants gave consent for research publications from the anonymised datafile.
: Not applicable.
: All authors contributed to the development of the concept and design of the study. ED undertook the statistical analysis and prepared a first draft of the manuscript. AH and DW contributed to the interpretation and writing the manuscript. CON obtained funding for data collection, supplied the data, and contributed to the interpretation and writing of the manuscript. All authors played a role in the review of the analysis, interpretation of the results, and reviewing and recommending revisions to the final version of manuscript.